Berkeley Lights is a life sciences tools company that provides research and development services using micro-droplet technology intended to fundamentally change the way biological processes are done. The company was founded in 2011 by Bill Davidow, Igor Khandros, and Ming C. Wu. Berkeley Lights is headquartered in Emeryville, California and has offices in Europe and Asia.

The company’s proprietary technology - automation, optimized workflows, software, consumables, assay reagents - enables scientists to find the best cells, the first time they look. Berkeley Lights’ platform accelerates the use of cell-based products by providing researchers access to the Berkeley Lights Platform to find the best cells in a fraction of the time and at a fraction of the cost of traditional methods.

Berkeley Lights’ mission is to accelerate the use of cell-based products by providing researchers access to the Berkeley Lights Platform to find the best cells in a fraction of the time and at a fraction of the cost of traditional methods.

Berkeley Lights went public on July 16th, 2020 under NASDAQ ticker symbol BLI. Berkeley Lights later acquired IsoPlexis in 2022 and the combined company is now named PhenomeX (Nasdaq: CELL),